Skip to main content

Financial News

  • Rite Aid comps rise 2.2% in January

    CAMP HILL, Pa. — Rite Aid's comps increased 2.2% for the month of January, compared with January 2011, the company said Thursday.

    Announcing results of the four-week period that ended Saturday, the retail pharmacy chain said January front-end comps increased 2.7%, while pharmacy comps increased 2.1%, including a negative effect of 230 basis points from new generic introductions. Prescription count at comparable stores increased by 1.6%.

  • Walgreens fortifies its specialty pharmacy arm

    DEERFIELD, Ill. — Walgreens on Thursday inserted another piece into its comprehensive healthcare offering, just in time for the PBM selling season, with the acquisition of BioScrip's community specialty pharmacies.

    Walgreens and BioScrip announced that they have entered into a definitive agreement under which Walgreens will acquire certain assets of BioScrip's community specialty pharmacies and centralized specialty and mail-service pharmacy businesses for a total deal value of approximately $225 million.

  • Sales rise, comps drop at Fred's

    MEMPHIS — Fred's on Thursday said January sales rose 3% to $132.4 million, compared with the year-ago period.

    Comparable-store sales for the retailer, however, declined 0.8%, compared with an increase of 2.1% in the same period last year.

  • Prestige officially acquires 15-of-17 GSK legacy brands

    IRVINGTON, N.Y. — Prestige Brands on Tuesday announced that it has completed its previously announced purchase of 15-of-the-17 brands it agreed to acquire from GlaxoSmithKline.

    Prestige did not identify the two brand acquisitions not yet completed.

    The former GSK brands represent approximately $200 million in annual revenues, which is projected to push Prestige annual revenues above $600 million, Prestige stated in an investor presentation in December.

  • Winn-Dixie sets date for shareholders' vote on Bi-Lo acquisition

    JACKSONVILLE, Fla. — Winn-Dixie on Tuesday announced it will hold a special meeting of shareholders at Winn-Dixie’s headquarters on March 9 to vote on the proposed Bi-Lo buyout of the southeastern grocer.

    Under the terms of that definitive agreement, Bi-Lo will acquire all of the outstanding shares of Winn-Dixie stock in the merger at $9.50 in cash per share of Winn-Dixie common stock, representing a premium of approximately 75% over the closing price of Winn-Dixie common stock on Dec. 16.

  • NRF: Valentine’s Day total spending to hit $17.6 billion

    WASHINGTON, — Consumers are set to pull out all the stops this Valentine’s Day, with the average person shelling out $126.03, up 8.5% over last year, according to the National Retail Federation’s "2012 Valentine’s Day Consumer Intentions and Actions" survey, conducted by BIGinsight. Total spending is expected to reach $17.6 billion.

  • Impax licenses migraine drug rights from AstraZeneca

    HAYWARD, Calif. — Impax Pharmaceuticals said Wednesday that it obtained exclusive U.S. commercial rights to a drug for migraine headaches made by AstraZeneca.

  • Katz Group to sell independent, franchise businesses to McKesson

    TORONTO — In an effort to strengthen its focus on its corporate-owned Rexall and Rexall/Pharma Plus store network, Katz Group Canada has signed a definitive agreement to sell its banner pharmacy business, Drug Trading, and its franchise pharmacy business, Medicine Shoppe Canada, to McKesson for about CAD $920 million in cash.

    The transaction, which is subject to customary closing conditions, including the receipt of Canadian regulatory clearances, is expected to close in the first half of 2012.

X
This ad will auto-close in 10 seconds